# Ulysses Capital

> Ulysses Capital is a VC fund backing Beauty, Energy and FinTech. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026

Ulysses Capital is a diversified investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Beauty | 1 | 17% |
| Energy | 1 | 17% |
| FinTech | 1 | 17% |
| Finance | 1 | 17% |
| Biopharma | 1 | 17% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Pre-Seed | 1 | 17% |
| Series C | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 4 | 67% |
| United States | 2 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pearl Health | Pearl Health’s mission is to democratize access to value in healthcare.Pearl empowers primary care physicians to deliver better quality care for their patients at a lower cost via a physician enablement technology platform and a value-based payment model.Pearl’s technology provides visibility into patient panel health, simple financialreporting, and recommendations to deliver care to patients who need it most.To date, we have raised more than $20m from investors including Andreessen Horowitz and AlleyCorp, and we’re working with 300+ physicians and 20,000+ lives in value-based models. | $50M | Series C | Jul 08, 2026 |  |
| Best Innovation | Best Innovation is a manufacturer of cosmetic products intended to offer a safe alternative to harmful skincare chemicals. | $15.8M | Seed | Jan 15, 2025 |  |
| Oilnow Korea | Oilnow Korea provides real-time gas station price comparison information. |  | Seed | Aug 01, 2022 |  |
| high-home.com | TRDST is an e-commerce platform for luxury furniture. |  | Seed | Jan 28, 2022 |  |
| VERTICAH | VERTICAH is a growth platform for start-ups that offers alternative financing, venture capital, and asset management services. | $495K | Pre-Seed | Jan 10, 2022 |  |
| Compass Therapeutics | Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, developing antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain enabled multispecific platforms to empirically identify multispecifics and combinations of antibody therapeuticsthat can be advanced to the clinic. The company's lead product candidate, CTX-009, is a bispecific antibody, which inhibits both DLL4-mediated Notch signaling and VEGF-A signaling. CTX-009 has completed a Phase 1 dose escalation study and is in a Phase 1b study in combination with chemotherapy in patients with solid tumors. The company’s second product candidate, CTX-471, is a novel agonistic antibody of CD137, a co-stimulatory receptor on immune cells. It is currently being evaluated in a Phase 1b study in patients who were previously treated with PD-1/PD-L1 checkpoint inhibitors, and who subsequently relapsed or progressed after a period of stable disease. Compass’ third product candidate, CTX-8371, is a bispecific antibody that blocks both PD-1 and PD-L1 and is in IND-enabling studies. The company was founded in 2014 and is headquartered in Boston, Massachusetts. | $60.5M | Venture - Series Unknown | Jun 23, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 3 deals together
- [Borealis Ventures](https://shizune.co/investors/profile/borealis-ventures) — VC Fund, 2 deals together
- [Fast Ventures](https://shizune.co/investors/profile/fast-ventures) — VC Fund, 2 deals together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together
- [AlleyCorp](https://shizune.co/investors/profile/alleycorp) — VC Fund, 1 deal together
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Unilever Ventures](https://shizune.co/investors/profile/unilever-ventures) — VC Fund
- [Fab Co-Creation Studio Ventures](https://shizune.co/investors/profile/fab-co-creation-studio-ventures) — VC Fund
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Proptech Investors in South Korea](https://shizune.co/investors/proptech-investors-south-korea)
- [Energy Investors in South Korea](https://shizune.co/investors/energy-investors-south-korea)
- [Real Estate Investors in South Korea](https://shizune.co/investors/real-estate-investors-south-korea)
- [Real Estate VC Funds in South Korea](https://shizune.co/investors/real-estate-vc-funds-south-korea)
- [Venture Capital Investors in South Korea](https://shizune.co/investors/venture-capital-investors-south-korea)
- [Finance Investors in South Korea](https://shizune.co/investors/finance-investors-south-korea)

## FAQ

### What does Ulysses Capital invest in?

Ulysses Capital invests primarily in Beauty, Energy and FinTech startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ulysses Capital last invest?

The most recent investment recorded for Ulysses Capital closed in Jul 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co